These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 38992762

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
    Zhang L, Liu Z, Dong Y, Kong L.
    Life Sci; 2021 Jul 01; 276():119412. PubMed ID: 33774025
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CRISPR-Cas9 based knockout of S100A8 in mammary epithelial cells enhances cell proliferation and triggers oncogenic transformation via the PI3K-Akt pathway: Insights from a deep proteomic analysis.
    Singh P, Ali SA, Kumar S, Mohanty AK.
    J Proteomics; 2023 Sep 30; 288():104981. PubMed ID: 37544501
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW, Wang SH, Wei X, Hou YZ, Li ZH.
    Eur Rev Med Pharmacol Sci; 2020 Dec 30; 24(24):12655-12666. PubMed ID: 33378012
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of keloids through Runx2 siRNA‑induced inhibition of the PI3K/AKT signaling pathway.
    Lv W, Wu M, Ren Y, Luo X, Hu W, Zhang Q, Wu Y.
    Mol Med Rep; 2021 Jan 30; 23(1):. PubMed ID: 33200804
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X, Dong J, He X, Shen L, Long C, Liu F, Liu X, Lin T, He D, Wei G.
    Biomed Pharmacother; 2020 May 30; 125():109880. PubMed ID: 32004974
    [Abstract] [Full Text] [Related]

  • 18. Multiomics and bioinformatics identify differentially expressed effectors in the brain of Toxoplasma gondii infected masked palm civet.
    Yuan H, Jiang T, Zhang WD, Yang Z, Luo S, Wang X, Zhu X, Qi S, Mahmmod YS, Zhang XX, Yuan ZG.
    Front Cell Infect Microbiol; 2023 May 30; 13():1267629. PubMed ID: 37818043
    [Abstract] [Full Text] [Related]

  • 19. [COL11A1 regulates PI3K/Akt/GSK-3β pathway and promotes human lung adenocarcinoma primary cell migration and invasion].
    Yang SY, Zhu LH, Yang R, Liao TT, Hu XW.
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jun 12; 46(6):580-586. PubMed ID: 37278172
    [Abstract] [Full Text] [Related]

  • 20. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M, Liu J, Mei C, Shi Y, Liu N, Jiang X, Liu C, Xue N, Hong H, Xie J, Sun X, Yin B, Meng X, Wang B.
    J Exp Clin Cancer Res; 2022 May 17; 41(1):175. PubMed ID: 35581606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.